Our observation that NEP abrogates breast cancer cell invasion (Figure 2) suggests that epithelial-specific reactivation of NEP could serve as a potential future therapy for the treatment of invasive breast cancer, assuming further research supports the utility of this approach. Here, MME is linked to invasive breast carcinoma.